- Report
- July 2024
- 233 Pages
Global
From €1719EUR$1,859USD£1,446GBP
€2456EUR$2,655USD£2,066GBP
- Report
- July 2024
- 228 Pages
Global
From €1719EUR$1,859USD£1,446GBP
€2456EUR$2,655USD£2,066GBP
- Report
- November 2023
- 250 Pages
Global
From €2312EUR$2,499USD£1,944GBP
€3303EUR$3,570USD£2,777GBP
- Report
- August 2023
- 293 Pages
Global
From €2312EUR$2,499USD£1,944GBP
€3303EUR$3,570USD£2,777GBP
- Report
- June 2023
- 243 Pages
Global
From €2312EUR$2,499USD£1,944GBP
€3303EUR$3,570USD£2,777GBP
- Report
- April 2023
- 252 Pages
Global
From €2312EUR$2,499USD£1,944GBP
€3303EUR$3,570USD£2,777GBP
- Report
- February 2023
- 300 Pages
Global
From €2312EUR$2,499USD£1,944GBP
€3303EUR$3,570USD£2,777GBP
- Report
- December 2022
- 229 Pages
Global
From €2312EUR$2,499USD£1,944GBP
€3303EUR$3,570USD£2,777GBP
- Report
- July 2022
- 274 Pages
Global
From €2389EUR$2,583USD£2,010GBP
€3414EUR$3,690USD£2,871GBP
- Report
- June 2022
- 230 Pages
Global
From €2238EUR$2,419USD£1,882GBP
€3197EUR$3,456USD£2,689GBP
- Report
- March 2022
- 225 Pages
Global
From €2312EUR$2,499USD£1,944GBP
€3303EUR$3,570USD£2,777GBP
- Report
- June 2021
- 245 Pages
Global
From €2404EUR$2,598USD£2,022GBP
€3434EUR$3,712USD£2,888GBP
- Report
- April 2023
- 300 Pages
Global
From €2312EUR$2,499USD£1,944GBP
€3303EUR$3,570USD£2,777GBP
- Book
- May 2018
- 1064 Pages
- Book
- September 2023
- 384 Pages
- Book
- February 2023
- 448 Pages
- Book
- November 2019
- 440 Pages
- Book
- November 2019
- 368 Pages
- Book
- June 2019
- 496 Pages
- Book
- June 2019
- 304 Pages

The Antibodies market is a subset of the Immune Disorders Drugs market, which focuses on treatments for conditions related to the immune system. Antibodies are proteins produced by the body to fight off foreign substances, such as bacteria and viruses. They are used to treat a variety of immune-related conditions, including autoimmune diseases, allergies, and cancer. Antibodies can be used in combination with other drugs, such as steroids, to reduce inflammation and improve symptoms. They can also be used to target specific cells or proteins in the body, allowing for more targeted treatments.
The Antibodies market is highly competitive, with a number of companies offering a variety of products. Companies such as AbbVie, Amgen, and Biogen are leading the way in developing and marketing antibodies for the treatment of immune-related conditions. Other companies, such as Genentech and Regeneron, are also active in the market, offering a range of products for different conditions. Show Less Read more